Cansino Biologics Inc (688185) — Financial Flexibility Index
Cansino Biologics Inc (688185) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥74.76 Million (operating CF CN¥30.53 Million minus capex CN¥44.23 Million) represents 0% of total liabilities (CN¥2.37 Billion). Also explore how fast is Cansino Biologics Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cansino Biologics Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Cansino Biologics Inc across 9 annual periods. Check Cansino Biologics Inc (688185) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cansino Biologics Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Cansino Biologics Inc. For the full company profile including market capitalisation, see 688185 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.09x | CN¥288.85 Million | CN¥-168.79 Million | CN¥3.05 Billion | ▲ +224.9% |
| 2023 | -0.08x | CN¥-305.78 Million | CN¥-916.25 Million | CN¥4.03 Billion | ▲ +60.6% |
| 2022 | -0.19x | CN¥-812.59 Million | CN¥-1.89 Billion | CN¥4.22 Billion | ▼ -119.9% |
| 2021 | 0.97x | CN¥3.22 Billion | CN¥2.01 Billion | CN¥3.33 Billion | ▲ +429.8% |
| 2020 | -0.29x | CN¥-198.62 Million | CN¥-469.39 Million | CN¥677.22 Million | ▼ -73.0% |
| 2019 | -0.17x | CN¥-53.24 Million | CN¥-170.19 Million | CN¥313.98 Million | ▼ -234.4% |
| 2018 | 0.13x | CN¥37.04 Million | CN¥-123.64 Million | CN¥293.56 Million | ▼ -74.8% |
| 2017 | 0.50x | CN¥129.59 Million | CN¥-56.30 Million | CN¥259.03 Million | ▼ -39.1% |
| 2016 | 0.82x | CN¥91.70 Million | CN¥-34.38 Million | CN¥111.70 Million | — |